Literature DB >> 113459

Activation of complement by Schistosoma mansoni schistosomula: killing of parasites by the alternative pathway and requirement of IgG for classical pathway activation.

F Santoro, P J Lachmann, A Capron, M Capron.   

Abstract

Living Schistosoma mansoni schistosomula incubated with normal chicken, guinea pig, human, and monkey sera were killed after 4 hr contact at 37 degrees C. The following data indicate that this action is dependent on the activation of the alternative complement pathway (AP): a) the inactivity of RB, RD, and zymosan-treated serum against schistosomula; b) the partial activity of RD restored in FD; c) the full effect of the C4-deficient guinea pig, C2-deficient human, and the agammaglobulinemic human sera; d) the consumption of both the AP and FB after the incubation of NHS with schistosomula; e) the detection of C3d breakdown product during the contact of the C2-deficient human serum with these young parasites. Killing by serum was decreased as the immature schistosomes developed and was completely absent against 4-day-old lung schistosomula (LS). In other experiments, it was demonstrated that schistosomula, in the presence of IgG, were able to initiate complement activation also through the classical pathway (CP). However, the CP does not appear to play a role in the schistosomulicidal activity of complement. The in vivo relevance of these observations is considered.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 113459

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

Review 1.  Complement evasion by parasites: search for "Achilles' heel".

Authors:  Z Fishelson
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

2.  Differential contribution of chemotaxins and opsonins to neutrophil-mediated killing of Schistosoma mansoni larvae.

Authors:  C H King; P J Spagnuolo; J J Ellner
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

3.  Schistosomiasis: immunologic properties of developing schistosomula.

Authors:  A Sher; G Moser
Journal:  Am J Pathol       Date:  1981-01       Impact factor: 4.307

Review 4.  Immunopathology of Schistosoma mansoni infection.

Authors:  D L Boros
Journal:  Clin Microbiol Rev       Date:  1989-07       Impact factor: 26.132

Review 5.  Biology of the schistosome lung-stage schistosomulum.

Authors:  G N Gobert; M Chai; D P McManus
Journal:  Parasitology       Date:  2006-11-17       Impact factor: 3.234

6.  Loss of complement activation and leukocyte adherence as Nippostrongylus brasiliensis develops within the murine host.

Authors:  Paul R Giacomin; Hui Wang; David L Gordon; Marina Botto; Lindsay A Dent
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

7.  Cercarial glycocalyx of Schistosoma mansoni activates human complement.

Authors:  J C Samuelson; J P Caulfield
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

8.  Comparison of the role of complement in immunity to Schistosoma mansoni in rats and mice.

Authors:  D A Vignali; Q D Bickle; M G Taylor; G Tennent; M B Pepys
Journal:  Immunology       Date:  1988-01       Impact factor: 7.397

9.  On the three-finger protein domain fold and CD59-like proteins in Schistosoma mansoni.

Authors:  Leonardo P Farias; Greice Krautz-Peterson; Cibele A Tararam; Bogar O Araujo-Montoya; Tatiana R Fraga; Henrique K Rofatto; Floriano P Silva; Lourdes Isaac; Akram A Da'dara; R Alan Wilson; Charles B Shoemaker; Luciana C C Leite
Journal:  PLoS Negl Trop Dis       Date:  2013-10-24

10.  Schistosoma tegument proteins in vaccine and diagnosis development: an update.

Authors:  Cristina Toscano Fonseca; Gardênia Braz Figueiredo Carvalho; Clarice Carvalho Alves; Tatiane Teixeira de Melo
Journal:  J Parasitol Res       Date:  2012-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.